Hebei New Century • Shengbo • Sheng'ao—making a dazzling appearance at the 22nd (2025) China Animal Husbandry Expo!

May 23,2025


In the bright month of May, with its azure seas and blue skies, the 22nd (2025) China Animal Husbandry Expo and the 2025 China International Animal Husbandry Expo will be held from May 19 to 21 at the Qingdao World Expo City. This year’s expo is themed “Showcasing New Business Models, Sharing New Achievements, Boosting New Momentum, and Leading New Development.” Over 1,500 companies from more than 20 countries and regions are participating in the expo, and four major international exhibition groups are showcasing cutting-edge technologies. Hebei New Century Pharmaceutical Co., Ltd., Shijiazhuang Shengbo Biotechnology Co., Ltd., and Shijiazhuang Sheng’ao Biotechnology Co., Ltd. are making impressive appearances at this year’s Animal Husbandry Expo.

 

Leaders visit the booth and show interest in the company’s development.

On the 19th, a delegation including Gu Chuanxue, former First-Level Inspector of the Hebei Provincial Department of Agriculture and Rural Affairs; Feng Xueling, former Second-Level Inspector of the same department; Zhao Jixiang, President of the Hebei Animal Husbandry Association; and Wu Tao, a Second-Level Researcher in the Division of Livestock and Poultry Slaughtering and Veterinary Drug & Feed Management, visited our booth to offer guidance and gain an understanding of the company’s participation in the exhibition as well as its overall business development. The delegation paid particular attention to the construction progress of Shijiazhuang Sheng’ao Biotechnology Co., Ltd. The leaders highly praised the important role played by Hebei New Century and Shengbo Bio in the development of the industry, encouraging us to keep forging ahead. They expressed their anticipation that Sheng’ao Bio will soon be completed and rapidly put into production, with its comprehensive product lineup leading the industry toward rapid growth.

 

 

 

Customers stop by the booth to discuss industry development.

        The creatively designed booth, coupled with the warm and hospitable attendees, and a comprehensive range of product formulations, attracted numerous domestic and international customers to stop by and engage in discussions. Researcher Mao Kairong, chief expert on brucellosis and from the China National Veterinary Drug Administration, provided guidance on the R&D and production of Shengbo Bio’s products. During the exhibition, Researcher Mao Kairong patiently answered customers’ questions and engaged in detailed communication with them. The professional explanations offered by the staff regarding both products and technologies, the sincere interactions with industry leaders, and the fruitful negotiations with prospective clients—combined with the constant stream of visitors at the booth—created a vibrant and eye-catching scene.

 

 

 

 

 

One exhibition brings the world together; one event showcases brilliance. Through this exhibition, by engaging in direct, face-to-face exchanges with customers and industry elites, we gain a deeper understanding of market demands and emerging trends, enabling us to more accurately grasp the direction of industry development and thus driving our company toward faster, more distinctive, and innovative growth. Hebei New Century Pharmaceutical, Shijiazhuang Shengbo Biotechnology, and Shijiazhuang Sheng'ao Biotechnology will remain true to our corporate mission: leading the future through technological innovation, earning market trust through integrity, and wholeheartedly serving the animal husbandry industry to promote its healthy and rapid development.


 


 


Hot News

Good news: Shengbo Bio and Sheng'ao Bio have both been approved for the Doctoral Innovation Station Construction Project!

Shengbo Bio and Sheng'ao Bio have both been recognized as recipients of the Doctoral Innovation Station Construction Project. This recognition is of great significance for enterprises in enhancing their innovation capabilities, optimizing their talent structure, and accelerating the commercialization of research findings.